The Master of Science in Drug Discovery and Modernization of Chinese Medicine (MSc-DDMCM) program at Hong Kong Baptist University offers a specialized curriculum for students interested in the intersection of traditional Chinese medicine and modern pharmaceutical science. This program aims to equip students with the knowledge and skills to explore the therapeutic potential of Chinese medicinal materials using contemporary scientific methodologies. Students will engage in comprehensive study covering various aspects of drug discovery, from the identification and extraction of active compounds in Chinese medicine to their pharmacological evaluation and potential development. The curriculum is designed to foster an understanding of both the theoretical underpinnings and practical applications in this evolving field, preparing graduates for research and development roles in the pharmaceutical and biotechnology industries.
The MSc-DDMCM program provides a structured curriculum over one year of full-time study.
Graduates of the MSc-DDMCM program are well-prepared for a variety of roles in the rapidly growing fields of drug discovery and pharmaceutical development, with a unique specialization in Chinese medicine.
Meeting the minimum requirements does not guarantee admission. Successful applicants will be selected based on academic merit and other relevant factors.
Tuition fees are subject to change. Please consult the University's official fee schedule for the most up-to-date information.
Applicants need a recognized Bachelor's degree in a relevant discipline, such as Pharmacy, Chemistry, Biology, Chinese Medicine, or a related field. Meeting minimum requirements does not guarantee admission, as selection is based on academic merit and other factors.
International applicants apply online through the HKBU admissions portal, submitting required documents like transcripts, degree certificates, English proficiency scores, and letters of recommendation. The application period typically opens in October/November and closes in January/February.
The Master of Science in Drug Discovery and Modernization of Chinese Medicine (MSc-DDMCM) program is designed for one year of full-time study.
Graduates can pursue roles such as Research Assistant/Associate, Drug Discovery Scientist, Product Development Specialist, Quality Control Analyst, or Regulatory Affairs Specialist in pharmaceutical and biotechnology industries.
International students may be eligible for the Targeted Taught Postgraduate Programmes Fellowships Scheme, offering up to HK$120,000 for full-time study, and the Hong Kong Future Talents Scholarship Scheme for Advanced Studies.
Specific tuition fees for international students are not detailed here. Please consult the official HKBU postgraduate admissions website for the most up-to-date fee schedules, as fees are subject to change.